Nate MeauxHead of Northeast Biopharma, Diagnostics and Tools, Silicon Valley Bank

Nathan has spent the last decade underwriting venture debt facilities for companies across the life sciences and healthcare spectrum with over $1Bn in commitments over that time. He is currently the Northeast Head of Biopharma/Diagnostics/Tools at SVB where his team oversees client relationships and helps prospects navigate the waters of venture debt and banking. Prior to rejoining SVB in early 2022, he was a member of the investment team at K2 HealthVentures where he was focused on venture debt and equity investments; due diligence, underwriting and management.